How Psychedelics Affect the Brain: The Discovery of a Shared Neural Fingerprint

Researchers have identified a shared neural fingerprint produced by five different psychedelic drugs in the human brain, revealing a common impact on brain behavior despite the substances having different chemistries. The study, published in Nature Medicine by Girn et al. In 2026, analyzed the effects of LSD, psilocybin, DMT, mescaline, and ayahuasca.

The discovery indicates that these mind-altering substances share a hallmark signature in how they temporarily rewire the brain. This finding is particularly significant as it marks the first time these five psychedelics have been analyzed together to determine their collective impact on neurological function.

The Mechanics of the Psychedelic Trip

The research found that the five drugs share a common ability to disrupt the standard organization of the brain. According to Dr. Danilo Bzdok, a senior author on the study from McGill University, these substances dissolve the common order, the usual hierarchy of brain systems.

By flattening this hierarchy, the drugs alter how the brain functions. Dr. Bzdok noted that this process probably underlies what some people describe as this raw access to one’s own consciousness.

The identified neural fingerprint consists of two primary shared patterns. First, there is stronger communication and increased cross-talk between distinct brain networks. Second, You’ll see selective reductions in connections within certain networks.

Scope and Scale of the Research

To build a reliable picture of these effects, an international team of researchers conducted a mega-analysis by pooling data from multiple sources. This approach allowed them to move beyond the small-scale, isolated studies that have traditionally characterized psychedelic research.

The data for the study included:

• 11 separate brain imaging datasets from around the world.
• A total of 519 brain scans.
• Participants consisting of 267 people across five different countries.

By combining these datasets, the team was able to identify a common denominator among drugs that were previously considered completely separate in their mechanisms.

Impacted Brain Regions

The researchers observed boosted interconnectivity across several key areas of the brain. This included cortical brain networks, which are responsible for higher-level thinking, as well as regions associated with touch and sight.

The study also found altered connections in deeper, subcortical regions of the brain. These include the putamen, the caudate, and the cerebellum, all of which are linked to how the brain coordinates perception and action.

Clinical Implications for Mental Health

The identification of this shared neural fingerprint provides critical insights for the medical community, as psychedelics are increasingly being investigated in clinical trials as potential therapies.

Researchers are exploring the use of these substances to treat severe neurological and mental health conditions, including:

• Depression
• Post-traumatic stress disorder (PTSD)
• Schizophrenia

Understanding the shared way these drugs rewire the brain may help scientists refine these treatments and better understand the biological basis of their therapeutic effects.

This is a breakthrough in how we think about psychedelic drugs. For the first time, we show there’s a common denominator among drugs that we currently consider completely separate.

Danilo Bzdok, McGill University